Lotfi Chalabi

发表

Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration.

B. Canaud, D. Krieter, H. Lemke, 2005, Kidney international.

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly.

M. Picot, J. Cristol, A. Dupuy, 2017, Kidney international.

Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.

I. Jaussent, C. Delcourt, J. Cristol, 2007, Nephrology, Dialysis and Transplantation.

Plasma PCSK9 concentrations during the course of nondiabetic chronic kidney disease: Relationship with glomerular filtration rate and lipid metabolism.

C. Le May, J. Cristol, B. Cariou, 2017, Journal of clinical lipidology.

FGF-23 removal is improved by on-line high-efficiency hemodiafiltration compared to conventional high flux hemodialysis.

J. Cristol, A. Dupuy, B. Canaud, 2013, Journal of nephrology.

Biocompatibility of heparin‐grafted hemodialysis membranes: Impact on monocyte chemoattractant protein‐1 circulating level and oxidative status

I. Jaussent, J. Cristol, A. Dupuy, 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.

I. Jaussent, C. Delcourt, J. Cristol, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?

J. Cristol, A. Dupuy, B. Canaud, 2016, Clinical chemistry and laboratory medicine.

Plasma osteoprotegerin is associated with mortality in hemodialysis patients.

I. Jaussent, C. Delcourt, J. Cristol, 2005, Journal of the American Society of Nephrology : JASN.

Randomised trial on clinical performances and biocompatibility of four high-flux hemodialyzers in two mode treatments: hemodialysis vs post dilution hemodiafiltration

J. Cristol, C. Créput, A. Dupuy, 2019, Scientific Reports.

Vitamin E-coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patients.

I. Jaussent, J. Cristol, A. Dupuy, 2013, Journal of nephrology.

Creatinine Index as a Surrogate of Lean Body Mass Derived from Urea Kt/V, Pre-Dialysis Serum Levels and Anthropometric Characteristics of Haemodialysis Patients

N. Molinari, J. Cristol, B. Canaud, 2014, PloS one.

Dynapenia and sarcopenia in chronic haemodialysis patients: do muscle weakness and atrophy similarly influence poor outcome?

J. Mercier, J. Cristol, F. Gouzi, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Physical inactivity and protein energy wasting play independent roles in muscle weakness in maintenance haemodialysis patients

J. Mercier, J. Cristol, F. Gouzi, 2018, PloS one.

Evaluation of a new point-of-care testing for creatinine and urea measurement

J. Cristol, T. Sutra, A. Dupuy, 2021, Scandinavian journal of clinical and laboratory investigation.

A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patients

I. Jaussent, J. Cristol, A. Dupuy, 2013, Clinical chemistry and laboratory medicine.